Jaye Thompson - 24 Dec 2024 Form 4 Insider Report for Greenwich LifeSciences, Inc. (GLSI)

Reporting relationship: VP Clinical Reg Affairs
Issuer ticker: GLSI
Reported as of: 24 Dec 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Dec 2024, 16:19:44 UTC
Prior SEC filing: 25 Nov 2024
Source filing: View source filing
Reporting owner signature: /s/ Jaye Thompson

Key filing fact

Jaye Thompson filed Form 4 for Greenwich LifeSciences, Inc. (GLSI) on 27 Dec 2024.

Key facts

This page summarizes Jaye Thompson's Form 4 filing for Greenwich LifeSciences, Inc. (GLSI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Dec 2024, 16:19.

Change

Previous filing in this sequence was filed on 25 Nov 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GLSI transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +149,818
Change %: +100%
Price: $0.000000
Shares after: 299,636
Date: 24 Dec 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 149,818
Exercise price: $12.16
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

37,455 options are earned upon date of grant and the remainder are earned monthly over 36 months. 10% of the earned options vest if reporting person has been employed by Issuer between 1-2 years from grant date, 20% of the earned options vest if reporting person has been employed by Issuer between 2-3 years from grant date, 30% of the earned options vest if reporting person has been employed by Issuer between 3-4 years from grant date and the remaining earned options vest if reporting person has been employed by Issuer more than 4 years after grant date.